IPO

With two pivotal trial readouts looming and cash projected to last only into Q4, Tvardi Therapeutics faces a make-or-break year for its STAT3 inhibitors.

Scooter giant Lime files for a landmark IPO, but its S-1 reveals massive debt, setting up a crucial test for the future of urban transport.

At a top Paris expo, GUYU's biotech arm BioQ unveiled cellular anti-aging ingredients, signaling a new era of Chinese innovation in the beauty supply chain.

Global insurer Fortegra appoints industry heavyweight Iwan Röpcke as CEO, Belgium, signaling a major strategic move into Europe's competitive specialty market.

A new fund, NICO, challenges ESG norms by investing in tobacco giants, aiming to force a shift to safer products. Can engagement succeed where exclusion has failed?

Despite strong earnings, LifeStance shares fall after a major investor sale. The company's own share repurchase signals a complex financial strategy.

Stroke recovery innovator Mobia Medical raised $150M in its IPO, but its stock stumbled on its first day, signaling a challenging road for its novel device.

The institutional crypto exchange is filing for CFTC licenses, a move that could unlock institutional capital and reshape the US digital asset market.

As it nears $10B in assets, investment firm Disruptive hires a top tech advisor, signaling a new phase of strategic growth for its unique investment model.

The firm's oversubscribed Collateralized Fund Obligation highlights a major shift in how institutional investors access private markets.

Phoenix-based DarkPulse gets exclusive rights to the Navy's cutting-edge laser targeting tech, but can the firm overcome financial hurdles to succeed?

From the makers of the 'World's Best Tequila,' a new Reposado redefines aging with a unique blend of Sauternes, Sherry, and Bourbon casks.

A newly public company says its patented device can make a standard gun less lethal. Can it truly bridge the gap between peace and lethal force?

A massive asset write-down reveals deep cable industry woes, but record mobile growth and aggressive cost-cutting show Optimum's strategy for survival.

Indian giant Godrej Industries Group unveils a bold plan to triple its market cap by 2031, blending its 129-year legacy with ambitious ESG goals.

Merchant bank Altea Partners appoints Nawaf AlOtaibi as CEO for its new Saudi platform, a strategic move to connect global capital with Vision 2030.

The thrift giant posts strong U.S. sales and a second quarter of adjusted profit growth, but a net loss and Canadian weakness reveal ongoing challenges.

HighPeak Energy posted strong Q1 operational results, but a $157M derivative loss highlights the challenges of navigating a volatile, geopolitically charged market.

The diagnostics firm's stellar quarter is fueled by surging test volumes and a new non-invasive prenatal test poised to disrupt high-risk screening.

LifeMD posts record subscriber growth in Q1 driven by GLP-1 and women's health, but a planned loss from heavy marketing spend raises key questions.